Patients with eosinophilic granulomatosis with polyangiitis experienced significant improvements in a variety of outcomes ...

Timmy Howard died just days after graduating from the University of Rhode Island. His parents are now bringing awareness to ...

As seasons change, temperatures rise and flowers begin to bloom, many find themselves battling more than just spring fever, ...

THE sun is shining, the sky is blue – yet for millions of us, this time of year can be pure hell. Instead of making the most ...

A study led by Johns Hopkins Medicine found a drug used to treat allergic asthma ... food allergies. The FDA did just that in February, making it the first medication to get approval to help ...

As the world grapples with chronic respiratory diseases, asthma profoundly impacts millions of lives. Characterized by ...

The global allergy immunotherapy market is projected to grow from USD 3.7 billion in 2025 to USD 5 billion by 2035, registering a CAGR of 3.5%, according to Future Market Insights on 22 May 2025. This ...

Since the European Medicines Agency (EMA) approval of omalizumab in 2005 as the first ever biologic for severe asthma, the respiratory community has seen a continuous growth in the number of biologics ...

(WOOD) — A drug ... reduce the risk of allergic reactions to food could bring relief to millions across the nation. Xolair was originally approved in 2003 for the treatment of moderate to severe ...

Xolair, an antibody asthma drug, was recently approved for ... While it will not eliminate food allergies or allow patients to consume food allergens freely, its repeated use will help reduce the ...

In short: The US Food and Drug Administration has approved the first medication to help reduce multiple food allergy reactions. The drug is used in Australia to treat asthma, hives and sinus ...

Researchers have found that Omalizumab, a drug commonly prescribed to treat asthma, could also limit “life-threatening reactions” to food allergies in children. Omalizumab, known under the ...